創薬アウトソーシング市場は2023年から2028年に17億9,000万米ドル、予測期間中のCAGRは7.44%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。バイオシミラーに対する旺盛な需要、コア・コンピタンスの優先順位付け、新興国市場におけるFDA承認製造施設の増加などが市場を牽引しています。
本調査では、創薬アウトソーシングを後押しする技術的進歩が、今後数年間の創薬アウトソーシング市場成長を牽引する主要因の1つであるとしています。また、再生医療需要の増加、創薬アウトソーシングのコスト削減・効率化需要も市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global drug discovery outsourcing market 2018 - 2022
4.2 Product Segment Analysis 2018 - 2022
4.3 End-user Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Product
6.1 Market segments
6.2 Comparison by Product
6.3 Small-molecules - Market size and forecast 2023-2028
6.4 Biologics - Market size and forecast 2023-2028
6.5 Market opportunity by Product
7 Market Segmentation by End-user
7.1 Market segments
7.2 Comparison by End-user
7.3 Big pharmaceutical companies - Market size and forecast 2023-2028
7.4 Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028
7.5 Generic pharmaceutical companies - Market size and forecast 2023-2028
7.6 Market opportunity by End-user
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 UK - Market size and forecast 2023-2028
9.9 Germany - Market size and forecast 2023-2028
9.10 Canada - Market size and forecast 2023-2028
9.11 Japan - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Aragen Life Sciences Pvt. Ltd.
12.4 Catalent Inc.
12.5 Charles River Laboratories International Inc.
12.6 Curia Global Inc.
12.7 Domainex
12.8 Eurofins Scientific SE
12.9 Evotec SE
12.10 GenScript Biotech Corp.
12.11 LABORATORY CORPORATION OF AMERICA HOLDINGS
12.12 Lonza Group Ltd.
12.13 Lupin Ltd.
12.14 Oncodesign Services
12.15 PerkinElmer Inc
12.16 QIAGEN NV
12.17 Thermo Fisher Scientific Inc.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global drug discovery outsourcing market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Small-molecules - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Small-molecules - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Small-molecules - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Small-molecules - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ billion)
Exhibits43: Data Table on Market opportunity by Product ($ billion)
Exhibits44: Chart on End-user - Market share 2023-2028 (%)
Exhibits45: Data Table on End-user - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by End-user ($ billion)
Exhibits61: Data Table on Market opportunity by End-user ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibits112: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibits113: Aragen Life Sciences Pvt. Ltd. - Key offerings
Exhibits114: Catalent Inc. - Overview
Exhibits115: Catalent Inc. - Business segments
Exhibits116: Catalent Inc. - Key offerings
Exhibits117: Catalent Inc. - Segment focus
Exhibits118: Charles River Laboratories International Inc. - Overview
Exhibits119: Charles River Laboratories International Inc. - Business segments
Exhibits120: Charles River Laboratories International Inc. - Key news
Exhibits121: Charles River Laboratories International Inc. - Key offerings
Exhibits122: Charles River Laboratories International Inc. - Segment focus
Exhibits123: Curia Global Inc. - Overview
Exhibits124: Curia Global Inc. - Product / Service
Exhibits125: Curia Global Inc. - Key offerings
Exhibits126: Domainex - Overview
Exhibits127: Domainex - Product / Service
Exhibits128: Domainex - Key offerings
Exhibits129: Eurofins Scientific SE - Overview
Exhibits130: Eurofins Scientific SE - Business segments
Exhibits131: Eurofins Scientific SE - Key news
Exhibits132: Eurofins Scientific SE - Key offerings
Exhibits133: Eurofins Scientific SE - Segment focus
Exhibits134: Evotec SE - Overview
Exhibits135: Evotec SE - Business segments
Exhibits136: Evotec SE - Key offerings
Exhibits137: Evotec SE - Segment focus
Exhibits138: GenScript Biotech Corp. - Overview
Exhibits139: GenScript Biotech Corp. - Business segments
Exhibits140: GenScript Biotech Corp. - Key offerings
Exhibits141: GenScript Biotech Corp. - Segment focus
Exhibits142: LABORATORY CORPORATION OF AMERICA HOLDINGS - Overview
Exhibits143: LABORATORY CORPORATION OF AMERICA HOLDINGS - Business segments
Exhibits144: LABORATORY CORPORATION OF AMERICA HOLDINGS - Key news
Exhibits145: LABORATORY CORPORATION OF AMERICA HOLDINGS - Key offerings
Exhibits146: LABORATORY CORPORATION OF AMERICA HOLDINGS - Segment focus
Exhibits147: Lonza Group Ltd. - Overview
Exhibits148: Lonza Group Ltd. - Business segments
Exhibits149: Lonza Group Ltd. - Key news
Exhibits150: Lonza Group Ltd. - Key offerings
Exhibits151: Lonza Group Ltd. - Segment focus
Exhibits152: Lupin Ltd. - Overview
Exhibits153: Lupin Ltd. - Product / Service
Exhibits154: Lupin Ltd. - Key news
Exhibits155: Lupin Ltd. - Key offerings
Exhibits156: Oncodesign Services - Overview
Exhibits157: Oncodesign Services - Product / Service
Exhibits158: Oncodesign Services - Key offerings
Exhibits159: PerkinElmer Inc - Overview
Exhibits160: PerkinElmer Inc - Business segments
Exhibits161: PerkinElmer Inc - Key news
Exhibits162: PerkinElmer Inc - Key offerings
Exhibits163: PerkinElmer Inc - Segment focus
Exhibits164: QIAGEN NV - Overview
Exhibits165: QIAGEN NV - Product / Service
Exhibits166: QIAGEN NV - Key offerings
Exhibits167: Thermo Fisher Scientific Inc. - Overview
Exhibits168: Thermo Fisher Scientific Inc. - Business segments
Exhibits169: Thermo Fisher Scientific Inc. - Key news
Exhibits170: Thermo Fisher Scientific Inc. - Key offerings
Exhibits171: Thermo Fisher Scientific Inc. - Segment focus
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations
